+86-21-58356573
LANGUAGE

Company news

ImmuneOnco announces acceptance of PCT application by China PCT-SAFE on a novel recombinant bi-functional protein licensed from third party

2015/11/16 0:00:00Click:700

     On November 16 of 2015, we have successfully confirmed acceptance of the application of PCT (PCT/CN2015/094739) by China PCT-SAFE on a novel engineered recombinant protein with two specific biological activities. This protein was licensed from a third company.